Availability of investigational drug, biological product, or

device Sec. 4. (a) A manufacturer of an investigational drug, biological product, or device may make available the investigational drug, biological product, or device to a qualified patient. (b) A manufacturer may do any of the following: (1) Provide an investigational drug, biological product, or device to a qualified patient without receiving compensation. (2) Require a qualified patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device. As added by P.L.2-2015, SEC.3.